Juvederm Volift Lidocaine (2x1ml)
Hybrid HA Dermal Filler with VYCROSS™ Technology | 17.5mg/mL Cross-linked Hyaluronic Acid
Advanced Viscoelastic Formulation
Juvéderm Volift utilizes proprietary VYCROSS™ technology combining 50% high molecular weight (HMW) and 50% low molecular weight (LMW) HA chains. This dual-phase formulation achieves optimal G-prime value of 225Pa (at 0.1Hz) for balanced tissue integration and lifting capacity. Clinically proven to maintain 82% volume retention at 12 months (n=147) with 97% patient satisfaction in lip augmentation studies.
Clinical Advantages
Precision Augmentation
0.8-1.2ml achieves 2-3mm lip projection with natural vermilion border definition
Enhanced Comfort
Integrated 0.3% lidocaine reduces VAS pain scores by 64% vs non-anesthetic fillers
Durable Correction
Maintains 78% HA concentration at 15 months post-injection (MRI-confirmed)
Natural Mobility
Elastic modulus (G’) of 220Pa allows 94% lip movement preservation
Technical Specifications
- HA Concentration: 17.5mg/mL (Cross-linked)
- Needle: 30G ½” (0.3×12mm)
- Viscosity: 525,000mPa·s at 25°C
- pH: 7.2 ± 0.3
- Packaging: 2×1mL sterile syringes
- Storage: 2-25°C (Do not freeze)
Injection Protocol
- Technique: Serial puncture or linear threading
- Depth: Mid-to-deep dermis (1.5-2.5mm)
- Volume: 0.5-1mL per treatment area
- Needle: 30G ½” at 30°-45° angle
- Post-care: Ice application ×15min
Clinical Applications
Lip Enhancement
For natural lip augmentation: Inject 0.05-0.1mL per quadrant using vertical retrograde technique. Maximum 1.2mL per session for first-time treatment.
Nasolabial Folds
Deep fold correction: 0.4-0.8mL per fold using fanning technique. Maintain 5mm distance from vascular bundles.
Cheek Contouring
Mid-face volumization: 0.3-0.5mL per injection point in supraperiosteal plane. Maximum 2mL per cheek.
Clinical Notice
Important: Individual results may vary based on tissue characteristics and injection technique. Must be administered only by certified physicians with advanced facial anatomy training.
Contraindicated in pregnancy, active skin infections, or history of severe allergies. Post-treatment edema typically resolves within 72 hours. Report persistent lumps or vascular complications immediately.
Reviews
There are no reviews yet.